Petros Gatsios/LinkedIn
Nov 5, 2025, 06:51
Petros Gatsios Explains Why Europe Must Become Self-Sufficient in Maintaining Its Plasma Supply
PPTA Europe shared on LinkedIn:
”Plasma-derived medicinal products (PDMPs) are vital for patients with rare and serious conditions and can’t be made in a lab.
Yet the supply of these medicines is more important than ever.
In a guest article published in Tagesspiegel Background Gesundheit and E-Health, Petros Gatsios, Chairman of the Plasma Protein Therapeutics Association Germany, explains why Europe must become self-sufficient in maintaining its plasma supply and suggests patient-centric policies to better secure future supplies.
Read more about how Germany can lead the way toward a resilient, self-sufficient model in Europe.”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch
-
Feb 23, 2026, 16:36Stéphanie Roullet։ New Method to Explore Primary Haemostasis in Cirrhotic Patients
-
Feb 23, 2026, 16:33Salvatore Massimo Petrina: Top 5 Game-Changers in the AHA and ACC PE Guidelines
-
Feb 23, 2026, 16:21Azin Alizadehasl: Introducing the Second Edition of a New Book on Echocardiography and Cardiac MRI
-
Feb 23, 2026, 16:16Kalyan Roy: When and Why Blood Irradiation Matters in Transfusion Medicine
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology